<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; UTHR</title>
	<atom:link href="http://news.dailystocks.com/tag/uthr/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>United Therapeutics CEO Buys 13,649 Shares (UTHR)</title>
		<link>http://news.dailystocks.com/673/united-therapeutics-ceo-buys-13649-shares-uthr/</link>
		<comments>http://news.dailystocks.com/673/united-therapeutics-ceo-buys-13649-shares-uthr/#comments</comments>
		<pubDate>Thu, 14 Jun 2012 21:52:09 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Insider Buying]]></category>
		<category><![CDATA[UTHR]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=673</guid>
		<description><![CDATA[<p>United Therapeutics Corporation (NASDAQ: UTHR) CEO Martine A. Rothblatt, on Wednesday, bought 13,649 shares of the company for $43.60 per share.</p> <p>Rothblatt has purchased UTHR shares on 7 other occasions in the past year. The average price for these purchases has been $42.15 per share.</p> <p></p> <p>UTHR shares have fallen 3.32% so far this year, [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/673/united-therapeutics-ceo-buys-13649-shares-uthr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
